Cell Med­ica scoops Kite Phar­ma's Chris Now­ers as CEO; Shire vet jumps to Edi­Gene as CEO

→ With sev­er­al of Cell Med­ica’s pro­grams on track for clin­i­cal tri­als, Gregg San­do has de­cid­ed it’s time to pass the reins at the biotech he found­ed 12 years ago. The new CEO is Chris Now­ers, a Bris­tol-My­ers vet and one-time biotech CEO who jumps from Kite Phar­ma. In that role, he head­ed up the Eu­ro­pean op­er­a­tion and com­mer­cial­iza­tion ef­forts for Kite’s Yescar­ta. He is now ex­pect­ed to lever­age that ex­pe­ri­ence to dri­ve Cell Med­ica’s own CAR and TCR pro­grams, some of which are de­vel­oped in col­lab­o­ra­tion with aca­d­e­m­ic part­ners in Lon­don (where it’s head­quar­tered) and Hous­ton (where it has of­fices).

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER